Diagnostics & Research
The Diagnostics & Research industry has a total of 58 stocks, with a combined market cap of $692.32 billion, total revenue of $161.15 billion and a weighted average PE ratio of 62.97.
Market Cap
692.32B
Revenue
161.15B
Profits
11B
PE Ratio
62.97
Profit Margin
6.82%
Dividend Yield
0.22%
58 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 203.70B | -0.98% | 1,613,764 | 42.88B |
| 2 | DHR | Danaher Corporation | 151.18B | 1.10% | 6,209,808 | 23.88B |
| 3 | A | Agilent Technologies, Inc. | 38.62B | -1.04% | 1,112,200 | 6.51B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 37.07B | -0.02% | 688,510 | 3.90B |
| 5 | IQV | IQVIA Holdings Inc. | 33.64B | -1.53% | 1,548,358 | 15.41B |
| 6 | MTD | Mettler-Toledo International Inc. | 26.91B | -1.27% | 129,000 | 3.87B |
| 7 | WAT | Waters Corporation | 22.26B | -1.57% | 272,138 | 2.96B |
| 8 | NTRA | Natera, Inc. | 21.43B | -3.50% | 1,532,741 | 1.53B |
| 9 | LH | Labcorp Holdings Inc. | 20.84B | 0.27% | 410,959 | 13.01B |
| 10 | DGX | Quest Diagnostics Incorporated | 19.12B | 0.06% | 727,356 | 9.87B |
| 11 | ICLR | ICON Public Limited Company | 16.26B | -0.22% | 1,326,311 | 8.28B |
| 12 | ILMN | Illumina, Inc. | 14.92B | -3.09% | 4,222,608 | 4.37B |
| 13 | RVTY | Revvity, Inc. | 13.85B | -0.77% | 658,369 | 2.76B |
| 14 | MEDP | Medpace Holdings, Inc. | 10.37B | -1.34% | 303,724 | 2.11B |
| 15 | EXAS | Exact Sciences Corporation | 9.15B | -0.50% | 3,339,532 | 2.76B |
| 16 | QGEN | Qiagen N.V. | 8.55B | 2.59% | 1,257,210 | 1.98B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.34B | 0.47% | 991,876 | 4.05B |
| 18 | GH | Guardant Health, Inc. | 5.30B | -9.56% | 5,715,204 | 739.02M |
| 19 | RDNT | RadNet, Inc. | 4.40B | -5.11% | 987,537 | 1.77B |
| 20 | SHC | Sotera Health Company | 3.83B | - | 810,848 | 1.12B |
| 21 | VCYT | Veracyte, Inc. | 3.04B | -4.56% | 815,105 | 425.33M |
| 22 | WGSWW | GeneDx Holdings Corp. | 2.63B | 8.70% | 30,880 | 305.45M |
| 23 | WGS | GeneDx Holdings Corp. | 2.63B | -5.66% | 1,086,733 | 305.45M |
| 24 | TWST | Twist Bioscience Corporation | 2.46B | -8.36% | 1,565,753 | 330.19M |
| 25 | NEOG | Neogen Corporation | 2.18B | - | 1,570,501 | 913.83M |
| 26 | NEO | NeoGenomics, Inc. | 1.43B | -6.41% | 1,877,747 | 660.57M |
| 27 | GRAL | GRAIL, Inc. | 1.37B | -14.72% | 2,830,717 | 125.60M |
| 28 | MYGN | Myriad Genetics, Inc. | 1.29B | -5.34% | 875,960 | 823.60M |
| 29 | CDNA | CareDx, Inc | 1.20B | -4.66% | 875,863 | 312.78M |
| 30 | OPK | OPKO Health, Inc. | 1.13B | 0.60% | 2,343,309 | 711.41M |
| 31 | CSTL | Castle Biosciences, Inc. | 721.19M | -1.53% | 285,748 | 311.88M |
| 32 | FLGT | Fulgent Genetics, Inc. | 503.46M | -1.02% | 201,959 | 277.76M |
| 33 | PSNL | Personalis, Inc. | 334.86M | -13.17% | 1,079,666 | 87.49M |
| 34 | ACRS | Aclaris Therapeutics, Inc. | 239.72M | -3.03% | 364,940 | 27.08M |
| 35 | STIM | Neuronetics, Inc. | 229.84M | -13.96% | 1,761,299 | 72.71M |
| 36 | ATLN | Atlantic International Corp. | 143.35M | 3.31% | 10,026 | 429.26M |
| 37 | NOTV | Inotiv, Inc. | 137.51M | -4.47% | 521,668 | 475.11M |
| 38 | BDSX | Biodesix, Inc. | 128.30M | -4.22% | 240,942 | 65.56M |
| 39 | FONR | FONAR Corporation | 93.39M | 0.28% | 6,861 | 101.57M |
| 40 | MDXH | MDxHealth SA | 87.96M | - | 35,823 | 84.71M |
| 41 | BNR | Burning Rock Biotech Limited | 73.35M | 0.70% | 840 | 72.83M |
| 42 | PRE | Prenetics Global Limited | 65.12M | -2.02% | 1,188 | 25.56M |
| 43 | ME | 23andMe Holding Co. | 64.92M | -11.68% | 346,880 | 208.78M |
| 44 | XGN | Exagen Inc. | 63.14M | -5.29% | 54,227 | 55.75M |
| 45 | OCX | OncoCyte Corporation | 55.82M | -2.57% | 51,726 | 709.00K |
| 46 | ENZ | Enzo Biochem, Inc. | 26.98M | -2.07% | 73,058 | 30.31M |
| 47 | PRPO | Precipio, Inc. | 15.03M | 5.90% | 77,513 | 17.41M |
| 48 | BIAF | bioAffinity Technologies, Inc. | 12.94M | 2.47% | 78,481 | 9.37M |
| 49 | BIAFW | bioAffinity Technologies, Inc. | 12.94M | 10.01% | 186,128 | 9.37M |
| 50 | PRPH | ProPhase Labs, Inc. | 12.75M | -9.49% | 14,200,313 | 12.75M |
| 51 | MYNZ | Mainz Biomed N.V. | 11.49M | 2.50% | 215,111 | 917.20K |
| 52 | APDN | Applied DNA Sciences, Inc. | 8.66M | -2.91% | 4,904,549 | 3.74M |
| 53 | STRR | Star Equity Holdings, Inc. | 7.05M | 0.92% | 3,954 | 50.38M |
| 54 | XWEL | XWELL, Inc. | 6.41M | 7.02% | 40,872 | 33.83M |
| 55 | CHEK | Check-Cap Ltd. | 4.53M | 0.12% | 69,681 | - |
| 56 | AWH | Aspira Women's Health Inc. | 3.67M | -3.08% | 307,319 | 8.96M |
| 57 | NDRA | ENDRA Life Sciences Inc. | 2.32M | -4.00% | 7,342 | - |
| 58 | ISPC | iSpecimen Inc. | 1.67M | -3.87% | 115,474 | 10.39M |